3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Classical hematology
1
Conditions
Breast Neoplasms
14
Polycystic Ovary Syndrome
12
Menorrhagia
7
Leiomyoma
7
Prostatic Neoplasms
2
Osteoporosis
2
Neoplasm Metastasis
2
Hyperandrogenism
2
Vaginitis
1
Triple Negative Breast Neoplasms
1
Sexual Dysfunction, Physiological
1
Neoplasms
1
Infertility, Female
1
Hot Flashes
1
Estrogen Receptor Positive Breast Cancer
1
Estrogen Levels Among Breast Cancer Patients
1
Coronary Disease
1
Cardiovascular Diseases
1
Breast Carcinoma In Situ
1
Atrophic Vaginitis
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Abortion, Spontaneous
1
Interventions
Acupuncture Therapy
10
Gabapentin
6
Venlafaxine Hydrochloride
4
Isoflavones
3
Estrogens, Conjugated (USP)
3
Bupivacaine
3
liposomal amphotericin B
2
fezolinetant
2
black cohosh root extract
2
Tamoxifen
2
Soybean Proteins
2
Sodium Chloride
2
Moxifloxacin
2
Magnesium Oxide
2
Hypnosis
2
Control Groups
2
Caspofungin
2
zopiclone
1
oxybutynin
1
bazedoxifene
1
Zolpidem
1
Vitamin B 6
1
Vancomycin
1
Therapeutics
1
Testosterone
1
Tazobactam
1
Tablets
1
Sugars
1
Solifenacin Succinate
1
Progesterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Hot Flashes
×
Estradiol
×
Clear all
NCT00303784
2020-11-27
PATCH
University College, London
Phase 3
Unknown
2,200 enrolled